Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Stragen Nordic is the Nordic affiliate of the Swiss-based Stragen Pharma Group, specializing in the development and commercialization of high-quality generic and value-added pharmaceutical products. The company focuses on therapeutic areas such as women's health, critical care, and oncology, providing essential medicines to hospitals and retail pharmacies across Denmark, Norway, Sweden, Finland, and Iceland. Stragen Nordic is known for its expertise in complex niche generics and hormone-based therapies, ensuring patient access to cost-effective treatments. Their business model emphasizes strategic partnerships for manufacturing and distribution while maintaining rigorous quality standards in line with European regulations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Stragen Nordic.